Westfield Capital Management
HAE icon

Westfield Capital Management’s Haemonetics HAE Stock Holding History

Westfield Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-805,916
Closed -$62.9M – 257
2024
Q4 		$62.9M Sell
805,916
-17,747
-2% -$1.43M 0.27% 114
2024
Q3 		$66.2M Buy
823,663
+80,783
+11% +$6.53M 0.3% 109
2024
Q2 		$61.5M Buy
742,880
+43,019
+6% +$3.78M 0.3% 110
2024
Q1 		$59.7M Sell
699,861
-12,200
-2% -$957K 0.31% 114
2023
Q4 		$60.9M Buy
712,061
+152,098
+27% +$13.1M 0.35% 111
2023
Q3 		$50.2M Buy
559,963
+151,144
+37% +$13.5M 0.34% 116
2023
Q2 		$34.8M Buy
408,819
+35,363
+9% +$2.99M 0.22% 145
2023
Q1 		$30.9M Buy
373,456
+49,898
+15% +$4.04M 0.22% 148
2022
Q4 		$25.4M Buy
323,558
+12,188
+4% +$980K 0.2% 150
2022
Q3 		$23.1M Sell
311,370
-7,720
-2% -$554K 0.18% 159
2022
Q2 		$20.8M Sell
319,090
-233,221
-42% -$13.8M 0.16% 167
2022
Q1 		$34.9M Sell
552,311
-735,366
-57% -$40M 0.22% 136
2021
Q4 		$68.3M Sell
1,287,677
-68,937
-5% -$4.2M 0.41% 85
2021
Q3 		$95.8M Buy
1,356,614
+562,628
+71% +$35.5M 0.58% 54
2021
Q2 		$52.9M Buy
793,986
+363,209
+84% +$25.7M 0.32% 119
2021
Q1 		$47.8M Sell
430,777
-101,865
-19% -$12.6M 0.3% 119
2020
Q4 		$63.3M Sell
532,642
-309,769
-37% -$33.3M 0.38% 90
2020
Q3 		$73.5M Buy
842,411
+579,943
+221% +$50.7M 0.48% 67
2020
Q2 		$23.5M Sell
262,468
-210,354
-44% -$21.2M 0.16% 157
2020
Q1 		$47.1M Sell
472,822
-133,252
-22% -$14.4M 0.42% 86
2019
Q4 		$69.6M Buy
606,074
+114,991
+23% +$13.9M 0.5% 69
2019
Q3 		$61.9M Sell
491,083
-29,095
-6% -$3.69M 0.5% 71
2019
Q2 		$62.6M Sell
520,178
-208,801
-29% -$20.5M 0.47% 74
2019
Q1 		$63.8M Buy
728,979
+19,027
+3% +$1.73M 0.49% 71
2018
Q4 		$71M Buy
709,952
+419,359
+144% +$44.1M 0.61% 63
2018
Q3 		$33.3M Buy
+290,593
New +$30.1M 0.23% 143

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Westfield Capital Management's HAE Position: Q1 2025 in Review

Westfield Capital Management sold out of Haemonetics (HAE) in Q1 2025, closing a stake of 805,916 shares — an estimated $62.9M sold.

Westfield Capital Management first reported a position in HAE in Q3 2018 and held it in 26 quarters. The position peaked at $95.8M in Q3 2021. 314 funds tracked by Wall St. Rank hold HAE as of Q1 2025.

  • Westfield Capital Management reported no remaining Haemonetics position as of Q1 2025 after selling out during the quarter.
  • Westfield Capital Management sold 805,916 Haemonetics shares in Q1 2025, an estimated $62.9M.
  • Westfield Capital Management first reported a position in Haemonetics in Q3 2018 and held it in 26 quarters.
  • Westfield Capital Management's Haemonetics position peaked at $95.8M in Q3 2021.
  • 314 funds tracked by Wall St. Rank held Haemonetics as of Q1 2025.

Based on Westfield Capital Management's 13F filing for Q1 2025, filed 9 May 2025.